Argenx
ARGX
₹49,990
Share price
6.36%
Change (1 day)
57.98%
Change (1 year)
Categories
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.
Earnings for Argenx (ARGX)
Earnings in 2024 (TTM): ₹7.34 Billion
According to Argenx 's latest financial reports the company's current earnings are ₹2.19 Billion. , an increase over its 2023 earnings that were of -₹26.21 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Argenx from 2013 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | ₹7.32 B | -127.97% |
| 2023 | -₹26.21 Billion | -58.25% |
| 2022 | -₹62.76 Billion | |
| 2019 | -₹17.13 Billion | 124.95% |
| 2018 | -₹7.62 Billion | 132.04% |
| 2017 | -₹3.29 Billion | 54.86% |
| 2016 | -₹2.12 Billion | 33% |
| 2015 | -₹1.6 Billion | 13.63% |
| 2014 | -₹1.41 Billion | 46.25% |
| 2013 | -₹0.96 Billion |